Search Results 51-60 of 17435 for triple negative breast cancer

  1. Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer - Mayo Clinic

    ... triple-negative breast cancer that has spread to other places in the body. Taselisib is a PI3K inhibitor. The PI3K pathway is involved is cancer growth.

  2. Mayo Clinic

    Triple-negative breast cancer patients should undergo genetic screening ... Triple-negative breast cancer patients should undergo genetic screening. 5X ...

  3. Chemotherapy For Breast Cancer Clinical Trials - Mayo Clinic Research

    ... triple negative metastatic breast cancer (TNMBC) or metastatic triple negative breast cancer. A Study of Combination Chemotherapy for Treating Women with ...

  4. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

    ... Triple Negative Breast Cancer. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information ...

  5. Mayo Clinic Q and A: Immunotherapy and breast cancer

    At this time, immunotherapy is approved primarily for patients with metastatic or locally advanced triple-negative breast cancer, which is an aggressive subtype ...

  6. Roberto A. Leon-Ferre, M.D. - Mayo Clinic Faculty Profiles

    Triple-negative breast cancer is the most aggressive type of breast cancer, affecting younger women and characterized by worse clinical outcomes. Dr. Leon-Ferre ...

  7. Recurrent Breast Cancer Clinical Trials - Mayo Clinic Research

    ... triple negative breast cancer that has spread to other parts of the body. Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ...

  8. Mayo Clinic Minute: Why Black women should consider screening for breast cancer earlier

    ... breast cancer 40% more often than white women. They also tend to have more aggressive cancers, known as triple-negative breast cancers," says Dr. Pruthi ...

  9. A Study of Niraparib Combined with Pembrolizumab (MK-3475) in Patients who have Triple-Negative Breast Cancer or Ovarian Cancer - Mayo Clinic

    Histologically proven advanced (unresectable) or metastatic cancer as outlined below. Patients with triple-negative breast cancer (TNBC) who have been ...

  10. Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer (ASCENT-04) - Mayo Clinic

    ... Triple-Negative Breast Cancer (ASCENT-04). Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More ...